The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Vascular Inflammation and the Renin-Angiotensin System
Abstract
It is now well established that vascular inflammation is an independent risk factor for the development of atherosclerosis. In otherwise healthy patients, chronic elevations of circulating interleukin-6 or its biomarkers are predictors for increased risk in the development and progression of ischemic heart disease. Although multifactorial in etiology, vascular inflammation produces atherosclerosis by the continuous recruitment of circulating monocytes into the vessel wall and by contributing to an oxidant-rich inflammatory milieu that induces phenotypic changes in resident (noninflammatory) cells. In addition, the renin-angiotensin system (RAS) has important modulatory activities in the atherogenic process. Recent work has shown that angiotensin II (Ang II) has significant proinflammatory actions in the vascular wall, inducing the production of reactive oxygen species, inflammatory cytokines, and adhesion molecules. These latter effects on gene expression are mediated, at least in part, through the cytoplasmic nuclear factor-kappaB transcription factor. Through these actions, Ang II augments vascular inflammation, induces endothelial dysfunction, and, in so doing, enhances the atherogenic process. Our recent studies have defined a molecular mechanism for a biological positive-feedback loop that explains how vascular inflammation can be self-sustaining through upregulation of the vessel wall Ang II tone. Ang II produced locally by the inflamed vessel induces the synthesis and…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The AngII–AT1R axis activates the NF-κB pathway through various growth factors and pro-inflammatory cytokines (347, 348).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [347]
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
Rajagopalan, S., Kurz, S. D., Münzel, T. F., Tarpey, M. M., Freeman, B. Α., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,467
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Research works printed but not linked: 63
- 10.1161/circ.104.3.365 · DOI
- 2000, Pharmacol Rev, 52, 11
- 10.1161/hyp.37.4.1047 · DOI
- 10.1161/circ.90.4.7923656 · DOI
- 1993, Arterioscler Thromb Vasc Biol, 12, 1125
- 1992, J Cardiovasc Pharmacol, 20, 38
- 10.1161/hyp.30.3.371 · DOI
- 10.1161/hyp.30.5.1183 · DOI
- 10.1161/circ.94.3.240 · DOI
- 10.1161/circ.101.14.1653 · DOI
- 10.1161/circ.101.20.2349 · DOI
- 10.1161/circ.101.13.1586 · DOI
- 2001, J Cardiovasc Pharmacol, 28, 395
- 10.1161/hyp.34.4.969 · DOI
- 1997, Lab Invest, 76, 835
- 10.1161/circ.103.3.448 · DOI
- 2001, J Clin Invest, 105, 1605
- 10.1161/res.74.6.8187280 · DOI
- 10.1161/circ.99.15.2027 · DOI
- 2001, Mol Cell Biochem, 212, 155
- 10.1161/hyp.29.1.366 · DOI
- 10.1161/res.87.12.1195 · DOI
- 10.1161/res.86.5.494 · DOI
- 10.1161/atvb.20.10.2175 · DOI
- 10.1161/res.88.9.888 · DOI
- 10.1161/atvb.21.9.1464 · DOI
- 10.1161/circ.100.9.899 · DOI
- 10.1161/atvb.20.3.645 · DOI
- 10.1161/circ.100.15.1646 · DOI
- 10.1161/circ.100.11.1223 · DOI
- 10.1161/circ.95.6.1532 · DOI
- 10.1161/res.84.6.695 · DOI
- 10.1161/atvb.19.7.1623 · DOI
- 1998, Nature, 294, 894
- 1991, Am J Physiol, 260, H1713
- 1996, Mol Endocrinol, 10, 252
- 10.1161/circ.99.16.2079 · DOI
- 10.1161/circ.101.15.1767 · DOI
- 2001, N Engl J Med, 342, 836
- 10.1161/circ.98.8.731 · DOI
- 10.1161/circ.97.5.425 · DOI
- 10.1161/atvb.17.6.1121 · DOI
- 10.1161/circ.99.2.237 · DOI
- 10.1161/circ.101.3.252 · DOI
- 2001, BMJ, 321, 199
- 2001, Eur Heart J, 21, 1584
- 10.1161/circ.97.20.2007 · DOI
- 10.1210/mend.16.4.0811 · DOI
- 1995, Ann N Y Acad Sci, 762, 12
- 10.1210/mend.15.3.0609 · DOI
- Brasier AR Recinos AI Eledrisi MS. Mechanisms for vascular inflammation as a cardiovascular risk factor.In: Runge M Patterson C eds. Principles of Molecular Cardiology. Totowa NJ: Humana Press; 2002.
- 1998, Endocrinology, 121, 1616
- 10.1161/circ.103.9.1194 · DOI
- 10.1161/circ.103.21.2531 · DOI
- 10.1161/circ.102.18.2165 · DOI
- 1997, Endocr Rev, 18, 662
- 1998, Nat Genet, 4, 59
- 10.3109/00365518709168886 · DOI
- 10.1161/res.57.2.3893789 · DOI
- 1975, J Reticuloendothel Soc, 17, 319
- 10.1161/circ.94.11.2756 · DOI
- 10.1161/circ.101.12.1372 · DOI
- 1997, Eur J Med Res, 2, 285
Cited by
Sorted by citations
Items 201–300 of 583
Türkmen, K., Oflaz, H., Uslu, B., Çimen, A. O., Elitok, A., Kaşıkçıoğlu, E., Alışır, S., Tufan, F., Namli, Ş., Uysal, M., et al. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02330607 · Cited by 47
Fukuda, D., Enomoto, S., Nagai, R., & Sata, M. (2009) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2009.02.006 · Cited by 47
Peng, N., Liu, J., Gao, D., Lin, R., & Li, R. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.09.007 · Cited by 47
Dectin-1 Acts as a Non-Classical Receptor of Ang II to Induce Cardiac Remodeling
Ye, S., Huang, H., Han, X., Luo, W., Wu, L., Ye, Y., Gong, Y., Zhao, X., Huang, W., Wang, Y., et al. (2023) · Circulation Research · doi:10.1161/circresaha.122.322259 · Cited by 46
Resolving fibrosis in the diseased liver: Translating the scientific promise to the clinic
Muddu, A. K., Guha, I. N., Elsharkawy, A. M., & Mann, D. A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.10.006 · Cited by 46
Amirbekian, S., Long, R. C., Consolini, M. A., Suo, J., Willett, N. J., Fielden, S., Giddens, D. P., Taylor, W. R., & Oshinski, J. N. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00889.2008 · Cited by 46
Tsubakimoto, Y., Yamada, H., Yokoi, H., Kishida, S., Takata, H., Kawahito, H., Matsui, A., Urao, N., Nozawa, Y., Hirai, H., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.187732 · Cited by 47
Wiesmann, M., Roelofs, M., Lugt, R. V. D., Heerschap, A., Kiliaan, A. J., & Claassen, J. A. H. R. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16667364 · Cited by 45
Zou, Z., Xu, J., Li, L., & Han, Y.-S. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.06.009 · Cited by 46
Walter, A., Étienne-Selloum, N., Sarr, M., Kane, M. O., Beretz, A., & Schini‐Kerth, V. B. (2008) · Journal of Vascular Research · doi:10.1159/000121408 · Cited by 47
Frohlich, E. D., & Sušić, D. (2011) · Heart Failure Clinics · doi:10.1016/j.hfc.2011.08.005 · Cited by 49
Recinos, A., Carr, B. K., Bartos, D. B., Boldogh, I. R., Carmical, J. R., Belalcazar, L. M., & Brasier, A. R. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00146.2003 · Cited by 45
Self-citationSrivastava, P., Badhwar, S., Chandran, D. S., Jaryal, A. K., Jyotsna, V. P., & Deepak, K. K. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.04.042 · Cited by 46
Russo, I. (2012) · Scientifica · doi:10.6064/2012/525374 · Cited by 47
Heart Failure-Induced Cachexia
Okoshi, M. P., Romeiro, F. G., de Paiva, S. A. R., & Okoshi, K. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20130060 · Cited by 44
Mechanisms for Cachexia in Heart Failure
Pureza, V. S., & Florea, V. G. (2013) · Current Heart Failure Reports · doi:10.1007/s11897-013-0153-9 · Cited by 44
Abareshi, A., Anaeigoudari, A., Norouzi, F., Shafei, M. N., Boskabady, M. H., Khazaei, M., & Hosseini, M. (2016) · Advances in Medicine · doi:10.1155/2016/7676512 · Cited by 44
Miyao, M., Cicalese, S. M., Kawai, T., Cooper, H. A., Boyer, M. J., Elliott, K. J., Forrester, S. J., Kuroda, R., Rizzo, V., Hashimoto, T. N., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093112 · Cited by 45
La inflamación en los síndromes coronarios agudos: mecanismos e implicaciones clínicas
Angiolillo, D. J., Biasucci, L. M., Liuzzo, G., & Crea, F. (2004) · Revista Española de Cardiología · doi:10.1016/s0300-8932(04)77128-6 · Cited by 44
Combined Therapy With a Calcium Channel Blocker and an Angiotensin II Type 1 Receptor Blocker
Bakris, G. L. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.08029.x · Cited by 44
Dörr, O., Liebetrau, C., Möllmann, H., Mahfoud, F., Ewen, S., Gaede, L., Troidl, C., Hoffmann, J., Busch, N., Laux, G. S., et al. (2014) · Clinical Research in Cardiology · doi:10.1007/s00392-014-0773-4 · Cited by 44
Marampon, F., Gravina, G. L., Scarsella, L., Festuccia, C., Lovat, F., Ciccarelli, C., ZANI, B. M., Polidoro, L., Grassi, D., Desideri, G., et al. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283638b32 · Cited by 43
Kim, H., Baek, C. H., Lee, R., Chang, J. W., Yang, W. S., & Lee, S. G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020305 · Cited by 43
Soehnlein, O., Schmeißer, A., Cicha, I., Reiss, C., Ulbrich, H. K., Lindbom, L., Daniel, W. G., & Garlichs, C. D. (2005) · Journal of Vascular Research · doi:10.1159/000087340 · Cited by 43
Angiotensin II, PPAR-Gamma and atherosclerosis
Kintscher, U. (2004) · Frontiers in bioscience · doi:10.2741/1225 · Cited by 42
Inflammation and Vascular Hypertrophy Induced by Angiotensin II
Schiffrin, E. L., & Touyz, R. M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000069907.12357.7e · Cited by 43
Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations
Ngo, D. T. M., Stafford, I., Sverdlov, A. L., Qi, W., Wuttke, R. D., Zhang, Y., Kelly, D. J., Weedon, H., Smith, M., Kennedy, J. A., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01084.x · Cited by 42
Direct Vascular Effects of Angiotensin II (A Systematic Short Review)
Nádasy, G. L., Balla, A., Dörnyei, G., Hunyady, L., & Szekeres, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010113 · Cited by 44
Ouzounian, M., Buth, K. J., Valeeva, L., Morton, C. C., Hassan, A., & Ali, I. S. (2012) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2011.10.058 · Cited by 40
Basic pathogenic mechanisms of atherosclerosis
Alfarisi, H. A. H., Mohamed, Z. B. H., & Ibrahim, M. (2020) · Egyptian Journal of Basic and Applied Sciences · doi:10.1080/2314808x.2020.1769913 · Cited by 43
C-Reactive Protein Elevation Predicts Pulse Pressure Reduction in Hypertensive Subjects
Amar, J., Ruidavets, J., Peyrieux, J., Mallion, J.-M., Ferrières, J., Safar, M. E., & Chamontin, B. (2005) · Hypertension · doi:10.1161/01.hyp.0000171165.80268.be · Cited by 40
Role of bone marrow renin–angiotensin system in the pathogenesis of atherosclerosis
Fukuda, D., & Sata, M. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.02.007 · Cited by 39
Long Noncoding RNAs in Atherosclerosis
Jian, L., Jian, D., Chen, Q., & Zhang, L. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.33167 · Cited by 39
EHP-101 alleviates angiotensin II-induced fibrosis and inflammation in mice
García‐Martín, A., Navarrete, C. M., Garrido‐Rodríguez, M., Prados, M. E., Caprioglio, D., Appendino, G., & Muñóz, E. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112007 · Cited by 39
Role of angiotensin II in retinal leukostasis in the diabetic rat
Chen, P., Scicli, G. M., Guo, M., Fenstermacher, J. D., Dahl, D., Edwards, P. A., & Scicli, A. G. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.05.009 · Cited by 39
Morphological and Molecular Changes of the Myocardium After Left Ventricular Mechanical Support
Baba, H. A., & Wohlschlaeger, J. (2008) · Current Cardiology Reviews · doi:10.2174/157340308785160606 · Cited by 39
Association between serum resistin and carotid intima media thickness in hypertension patients
Shin, H. J., Park, S., Yoon, S., Choi, D. S., Cho, D., Kim, J., Ko, Y., Choi, D., Jang, Y., & Chung, N. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.02.028 · Cited by 39
Iwashita, M., Sakoda, H., Kushiyama, A., Fujishiro, M., Ohno, H., Nakatsu, Y., Fukushima, T., Kumamoto, S., Tsuchiya, Y., Kikuchi, T., et al. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00324.2011 · Cited by 38
Anti-inflammatory Principles from Sarcandra glabra
Tsai, Y.-C., Chen, S.-H., Lin, L.-C., & Fu, S. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b05125 · Cited by 38
Wei, S., Yu, Y., & Felder, R. B. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00211.2017 · Cited by 39
Kim, H. J., Han, S. J., Kim, D. J., Jang, H. C., Lim, S. K., Choi, S. H., Kim, Y. H., Shin, D. H., Kim, S. H., Kim, T. H., et al. (2016) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.404 · Cited by 38
Supriya, R., Tam, B. T., Yu, A. P., Lee, P. H., Lai, C. W. K., Cheng, K. K. Y., Yau, S., Chan, L., Yung, B. Y., Sheridan, S. E., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201585 · Cited by 38
Nakano, A., Hattori, Y., Aoki, C., Jojima, T., & Kasai, K. (2009) · Hypertension Research · doi:10.1038/hr.2009.95 · Cited by 37
Role of Blood Cell–Associated AT1 Receptors in the Microvascular Responses to Hypercholesterolemia
Petnehazy, T., Stokes, K. Y., Wood, K. C., Russell, J., & Granger, D. N. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000193625.32499.71 · Cited by 37
Tolvaptan Improves Left Ventricular Dysfunction after Myocardial Infarction in Rats
Yamazaki, T., Izumi, Y., Nakamura, Y., Yamashita, N., Fujiki, H., Osada‐Oka, M., Shiota, M., Hanatani, A., Shimada, K., Iwao, H., et al. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.968750 · Cited by 36
Molecular Dissection of Angiotensin II–Activated Human LOX-1 Promoter
Chen, J., Liu, Y., Liu, H., Hermonat, P. L., & Mehta, J. L. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000209998.73303.b5 · Cited by 36
Ji, Y., Liu, J., Liu, N., Wang, Z., & Liu, C.-H. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.095 · Cited by 36
Thymus vulgaris, a natural pharmacy against COVID-19: A molecular review
Nadi, A., Shiravi, A. A., Mohammadi, Z. S., Amin, A., & Zeinalian, M. (2023) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2023.100635 · Cited by 36
The atherogenic potential of dietary carbohydrate
Kopp, W. (2006) · Preventive Medicine · doi:10.1016/j.ypmed.2006.02.003 · Cited by 36
Vaccine for hypertension: Modulating the renin–angiotensin system
Pandey, R., Quan, W. Y., Hong, F., & jie, S. L. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.03.032 · Cited by 35
Lin, C.-H., Liao, C., Huang, C.-H., Tung, Y., Chang, H.-C., Hsu, M., & Huang, C. (2017) · International Journal of Medical Sciences · doi:10.7150/ijms.17627 · Cited by 35
Sopel, M. J., Falkenham, A., Oxner, A., Ma, I., Lee, T. D. G., & Légaré, J. (2012) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2011.00797.x · Cited by 34
Lu, F. Y., Du, X., Gao, X., & Dart, A. M. (2010) · Clinical Science · doi:10.1042/cs20100011 · Cited by 33
Functional Long Non-coding RNAs in Vascular Smooth Muscle Cells
Leung, A., Stapleton, K., & Natarajan, R. D. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_441 · Cited by 32
Angiotensin II Increases Expression of IP-10 and the Renin-Angiotensin System in Endothelial Cells
Ide, N., Hirase, T., Nishimoto-Hazuku, A., Ikeda, Y., & Node, K. (2008) · Hypertension Research · doi:10.1291/hypres.31.1257 · Cited by 33
Jie, D. O. N. G., Fujii, S., Goto, D., Furumoto, T., Kaneko, T., ZAMAN, T. A., Nakai, Y., Mishima, T., Imagawa, S., & Kitabatake, A. (2003) · Hypertension Research · doi:10.1291/hypres.26.723 · Cited by 33
Sun, J., Gui, Y., Zhou, S., & Zheng, X. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.11.006 · Cited by 38
Sysoeva, V., Ageeva, L. V., Tyurin‐Kuzmin, P. A., Sharonov, G. V., Dyikanov, D. T., Kalinina, N., & Va, T. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.10.022 · Cited by 32
Mechanisms of hypertension in autoimmune rheumatic diseases
Taylor, E. B., Wolf, V., Dent, E. L., & Ryan, M. J. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14604 · Cited by 33
Role of the Immune System in Hypertension: Modulation by Dietary Antioxidants
Vasdev, S., Stuckless, J., & Richardson, V. J. (2011) · International Journal of Angiology · doi:10.1055/s-0031-1288941 · Cited by 32
The role of aldosterone in mediating the dependence of angiotensin hypertension on IL-6
Sturgis, L. C., Cannon, J. G., Schreihofer, D. A., & Brands, M. W. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90995.2008 · Cited by 33
Al‐Daghri, N. M., Al-Attas, O. S., Dahman, L. S. B., Alokail, M. S., Alkharfy, K. M., Draz, H. M., Yakout, S. M., McTernan, P. G., Sabico, S., & Chrousos, G. P. (2012) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2012.02714.x · Cited by 32
A functional (pro)renin receptor is expressed in human lymphocytes and monocytes
Narumi, K., Hirose, T., Sato, E., Mori, T., Kisu, K., Ishikawa, M., Totsune, K., Ishii, T., Ichihara, A., Nguyen, G., et al. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00206.2014 · Cited by 34
Acute Myocardial Infarction and Risk of Cognitive Impairment and Dementia: A Review
Thong, E. H., Quek, J. W. E., Loo, J. H., Yun, C.-Y., Teo, Y. N., Teo, Y. H., Leow, A. S., Li, T. Y., Sharma, V. K., Tan, B. Y., et al. (2023) · Biology · doi:10.3390/biology12081154 · Cited by 31
Birudaraju, D., Cherukuri, L., Kinninger, A., Chaganti, B. T., Shaikh, K. A., Hamal, S. A., Flores, F. R., Roy, S. K., & Budoff, M. J. (2019) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.09.011 · Cited by 32
Timasheva, Y., Насибуллин, Т. Р., Закирова, А. Н., & Mustafina, O. E. (2007) · Biochemical Genetics · doi:10.1007/s10528-007-9130-x · Cited by 31
Ryu, J., & Kim, S.-J. (2011) · Blood Purification · doi:10.1159/000326297 · Cited by 31
Anti-inflammatory Effect of Spironolactone on Human Peripheral Blood Mononuclear Cells
Miura, R., Nakamura, K., Miura, D., Miura, A., Hisamatsu, K., Kajiya, M., Nagase, S., Morita, H., KUSANO, K. F., Ohe, T., et al. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.sc0060049 · Cited by 31
Lee, T.-I., Kao, Y.-H., Chen, Y.-C., Huang, J.-H., Hsu, M., & Chen, Y.-J. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.08.051 · Cited by 30
Herpes Simplex Virus Type 2 Infection Is a Risk Factor for Hypertension
Sun, Y., Pei, W.-D., Wu, Y., Jing, Z., Zhang, J., & Wang, G. (2004) · Hypertension Research · doi:10.1291/hypres.27.541 · Cited by 30
Olkowicz, M., Chłopicki, S., & Smolenski, R. T. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.03.017 · Cited by 30
Zhang, X., Wu, M., Jiang, H., Hao, J., Zhang, Q., Zhu, Q. X., Saren, G., Zhang, Y., Meng, X., & Yue, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107634 · Cited by 29
Bersi, M. R., Collins, M. J., Wilson, E., & Humphrey, J. D. (2012) · International Journal of Advances in Engineering Sciences and Applied Mathematics · doi:10.1007/s12572-012-0052-4 · Cited by 29
Davis, D. A., Pellowski, D. M., Davis, D. A., & Donahoo, W. T. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803120 · Cited by 29
Petnehazy, T., Stokes, K. Y., Russell, J. M., & Granger, D. N. (2005) · Hypertension · doi:10.1161/01.hyp.0000154085.27868.93 · Cited by 29
The endocytosis of oxidized LDL via the activation of the angiotensin II type 1 receptor
Takahashi, T., Huang, Y., Yamamoto, K. I., Hamano, G., Kakino, A., Kang, F., Imaizumi, Y., Takeshita, H., Nozato, Y., Nozato, S., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102076 · Cited by 29
Occurrence of the JAK2 V617F mutation in patients with peripheral arterial disease
Muendlein, A., Kinz, E., Gasser, K., Leiherer, A., Rein, P., Saely, C. H., Grallert, H., Peters, A., Fraunberger, P., Drexel, H., et al. (2014) · American Journal of Hematology · doi:10.1002/ajh.23874 · Cited by 28
Neuroprotective role of angiotensin II type 2 receptor after transient focal ischemia in mice brain
Miyamoto, N., Zhang, N., Tanaka, R., Liu, M., Hattori, N., & Urabe, T. (2008) · Neuroscience Research · doi:10.1016/j.neures.2008.03.003 · Cited by 28
Effects of Cold Air on Cardiovascular Disease Risk Factors in Rat
Luo, B., Zhang, S., Ma, S., Zhou, J., & Wang, B. (2012) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph9072312 · Cited by 28
Tokumoto, M., Mizobuchi, M., Finch, J. L., Nakamura, H. K., Martin, D. R., & Slatopolsky, E. (2009) · American Journal of Nephrology · doi:10.1159/000192844 · Cited by 28
Telmisartan inhibits β2-integrin MAC-1 expression in human T-lymphocytes
Link, A., Lenz, M., Legner, D., Böhm, M., & Nickenig, G. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000242415.73406.17 · Cited by 27
The Protective Role of Sestrin2 in Atherosclerotic and Cardiac Diseases
Kishimoto, Y., Kondo, K. N., & Momiyama, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031200 · Cited by 28
Koga, J., Egashira, K., Matoba, T., Kubo, M., Ihara, Y., Iwai, M., Horiuchi, M., & Sunagawa, K. (2008) · Hypertension Research · doi:10.1291/hypres.31.1791 · Cited by 27
Marino, F., Guasti, L., Cosentino, M., Ferrari, M., Rasini, E., Maio, R. C., Cimpanelli, M. G., Cereda, E., Crespi, C., Simoni, C., et al. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31803d35ce · Cited by 27
α-1 Microglobulin as a New Inflammatory Marker in Newly Diagnosed Hypertensive Patients
Vyssoulis, G. P., Tousoulis, D., Antoniades, C. A., Dimitrakopoulos, S., Zervoudaki, A., & Stefanadis, C. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.01.010 · Cited by 27
Aldosterone Synthesis and Cytokine Production in Human Peripheral Blood Mononuclear Cells
Miura, R., Nakamura, K., Miura, D., Miura, A., Hisamatsu, K., Kajiya, M., Hashimoto, K., Nagase, S., Morita, H., KUSANO, K. F., et al. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0060801 · Cited by 27
Xu, X., Liu, S., Aodengqimuge, Wang, H., Hu, M., Chen, X., & Song, L. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx184 · Cited by 26
Stadler, J. T., Wadsack, C., & Marsche, G. (2021) · Biomedicines · doi:10.3390/biomedicines9040349 · Cited by 25
Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders
Sofias, A. M., Lorenzi, F. D., Peña, Q., Shalmani, A. A., Vucur, M., Wang, J., Kiessling, F. M., Shi, Y., Consolino, L., Storm, G., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113831 · Cited by 28
Li, G., Wang, M., Hao, L., Loo, W. T.-Y., Jin, L., Cheung, M., Chow, L. W. C., & Ng, E. L. Y. (2014) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2014.02.015 · Cited by 26
Liao, Z., Cai, H., Xu, Z., Wang, J., Qiu, C., Xie, J., Huang, W., & Sui, Z. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3846029 · Cited by 26
Li, J., Cao, G., Zhang, X., Meng, Z., Gan, L., Li, J., Lan, X., Yang, C.-L., & Zhang, C.-F. (2020) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x20500068 · Cited by 26
Caulfield, L., Heslop, P., Walesby, K. E., Sumukadas, D., Sayer, A. A., & Witham, M. D. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.07.012 · Cited by 25
Hou, X., Wang, L.-F., Wang, N., Pang, D., Hui, B., Zhou, Y., & He, X. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.11.016 · Cited by 25
Nakamura, T., Hasegawa‐Nakamura, K., Sakoda, K., Matsuyama, T., & Noguchi, K. (2011) · European Journal Of Oral Sciences · doi:10.1111/j.1600-0722.2011.00850.x · Cited by 25
Reims, H. M., Kjeldsen, S. E., Brady, W. E., Dahlöf, B., Devereux, R. B., Julius, S., Beevers, G., Fairé, U. D., Fyhrquist, F., Ibsen, H., et al. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001731 · Cited by 25
Ambrose, J. A., & D’Agate, D. J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.09.037 · Cited by 25
Fasolo, F., Paloschi, V., & Mäegdefessel, L. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.11.021 · Cited by 24
Inflammation in Acute Coronary Syndromes: Mechanisms and Clinical Implications
Angiolillo, D. J., Biasucci, L. M., Liuzzo, G., & Crea, F. (2004) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60174-6 · Cited by 24
Ogawa, S., Mori, T., Nako, K., Ishizuka, T., & Ito, S. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03450807 · Cited by 24
Metadata
- Authors
- Brasier, A. R., Recinos, A., & Eledrisi, M. S.
- Affiliations
- The University of Texas Medical Branch at Galveston (US)
- From the Departments of Medicine (A.R.B., A.R., M.S.E.) and Human Biological Chemistry and Genetics (A.R.B.) and the Sealy Center for Molecular Sciences (A.R.B.), The University of Texas Medical Branch, Galveston.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2002-08
- Volume
- 22
- Issue
- 8
- Pages
- 1257-1266
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2154360613
- Cited by
- 586
- References
- 126
- Citations by year
- 2026: 4 · 2025: 17 · 2024: 12 · 2023: 16 · 2022: 9 · 2021: 20 · 2020: 21 · 2019: 12 · 2018: 16 · 2017: 22 · 2016: 24 · 2015: 22 · 2014: 25 · 2013: 22 · 2012: 29
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (55630)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- vascular inflammation, renin-angiotensin system, angiotensin II, atherosclerosis, interleukin-6, nuclear factor-kappaB, JAK/STAT3 signaling, angiotensinogen, oxidized lipids, endothelial dysfunction, monocyte recruitment, reactive oxygen species, ischemic heart disease
- MeSH terms
- Acute-Phase Proteins, Angiotensin II, Animals, Arteriosclerosis, Endothelium, Vascular, Humans, Inflammation, Cholesterol, LDL, Liver, Macrophages, Monocytes, Oxidation-Reduction, Renin-Angiotensin System, Signal Transduction, Interleukin-6, Reactive Oxygen Species, Feedback, Physiological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review